Journal
TRENDS IN BIOTECHNOLOGY
Volume 38, Issue 4, Pages 360-367Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2019.09.009
Keywords
-
Categories
Funding
- Be READY project - Sciensano
Ask authors/readers for more resources
Next-generation sequencing (NGS) can enable a more effective response to a wide range of communicable disease threats, such as influenza, which is one of the leading causes of human morbidity and mortality worldwide. After vaccination, antivirals are the second line of defense against influenza. The use of currently available antivirals can lead to antiviral resistance mutations in the entire influenza genome. Therefore, the methods to detect these mutations should be developed and implemented. In this Opinion, we assess how NGS could be implemented to detect drug resistance mutations in clinical influenza virus isolates.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available